(Q34310199)

1 August 2017

1 reference

title

The effect of cholecystokinin in controlling appetite and food intake in humans (English)

1 reference

1 August 2017

1 reference

1 reference

Degen L

1

1 reference

1 August 2017

Matzinger D

series ordinal

2

1 reference

1 August 2017

Drewe J

series ordinal

3

1 reference

1 August 2017

Beglinger C

series ordinal

4

1 reference

1 August 2017

language of work or name

1 reference

1 August 2001

1 reference

1 August 2017

number of pages

5

1 reference

inferred from page(s)

published in

Peptides

1 reference

1 August 2017

volume

22

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

1265-1269

1 reference

Cholecystokinin is a satiety hormone in humans at physiological post-prandial plasma concentrations

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Dietary fat and the control of energy intake: evaluating the effects of fat on meal size and postmeal satiety

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Medicinal strategies in the treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Control of food intake. A physiologically complex, motivated behavioral system

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Impaired Cholecystokinin Secretion in Bulimia Nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Regulation of appetite and cholecystokinin secretion in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Gut peptides and food in the gut produce similar satiety effects

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Cholecystokinin decreases food intake in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Role of cholecystokinin in mediating GRP-stimulated gastric, biliary and pancreatic functions in man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

C-terminal octapeptide of cholecystokinin decreases food intake in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Satiety effects of cholecystokinin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Effects of a physiological dose of cholecystokinin on food intake and postprandial satiation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Fatty acids stimulate cholecystokinin secretion via an acyl chain length-specific, Ca2+-dependent mechanism in the enteroendocrine cell line STC-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Role of cholecystokinin in regulation of gastrointestinal motor functions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Disturbed cholecystokinin secretion in patients with eating disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Satiety and cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Induction of Fos-like immunoreactivity (Fos-li) and stimulation of feeding by 2,5-anhydro-D-mannitol (2,5-AM) require the vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

The direct and indirect controls of meal size

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

The satiety effect of cholecystokinin: A progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Abdominal Vagotomy Blocks the Satiety Effect of Cholecystokinin in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Satiety effects of cholecystokinin and ceruletide in lean and obese man.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Gustatory neural processing in the hindbrain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Effect of ileal and intravenous infusions of fat emulsions on feeding and satiety in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Comparisons of the effects on satiety and eating behaviour of infusion of lipid into the different regions of the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900450-8

7 January 2021

10.1016/S0196-9781(01)00450-8

Identifiers

DOI

1 reference

1 August 2017

1 reference